Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-009779
Filing Date
2025-04-02
Accepted
2025-04-02 19:03:08
Documents
1
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 form4-04022025_110404.html 4  
1 form4-04022025_110404.xml 4 5947
  Complete submission text file 0001415889-25-009779.txt   7427
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Issuer) CIK: 0001496323 (see all company filings)

EIN.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address
Topsoe Christina Teng (Reporting) CIK: 0001786442 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39045 | Film No.: 25806880